Kyverna Therapeutics Inc. (KYTX)
2.61
-0.23 (-8.10%)
At close: Mar 03, 2025, 3:59 PM
2.59
-0.77%
After-hours: Mar 03, 2025, 04:00 PM EST
Kyverna Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
24
Upside
819.54
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Mitchell Kapoor (0)
| HC Wainwright & Co. | Hold | Maintains | 7 6 | Nov 20, 2024 |
Derek Archila (0)
| Wells Fargo | Buy | Maintains | 44 24 | Nov 15, 2024 |
Trung Huynh (1.93)
| UBS | Buy | Initiates | 13 | Oct 10, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.